Intrommune Therapeutics
Pre-clinicalOur novel drug delivery platform provides a simple treatment for food allergies by embedding therapeutic agents in a functional toothpaste for daily use!
Founded
2015
Focus
Drug Delivery
About
Our novel drug delivery platform provides a simple treatment for food allergies by embedding therapeutic agents in a functional toothpaste for daily use!
Funding History
2Total raised: $15M
Series A$12MPontifaxSep 15, 2020
Seed$3MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationNew York, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile